Bruno Francois Jules Angelici
Chairman at Vectura GmbH
Profile
Bruno Francois Jules Angelici is currently the Chairman at Vectura GmbH.
He previously worked as Chairman at Vectura Group Ltd., Independent Non-Executive Director at Novo Nordisk A, Independent Non-Executive Director at Smiths Group Plc, EVP-International Sales & Marketing Organisation at AstraZeneca PLC, Independent Member-Supervisory Board at Wolters Kluwer NV, President-Latin America, Middle East & Africa at AstraZeneca, Inc., President at Astra Zeneca Holding France SAS, and President at Astrazeneca Japan Ltd.
Mr. Angelici received his undergraduate degree from Ecole Supérieure de Commerce de Reims, his graduate degree from the University of Reims Champagne-Ardenne, and his MBA from Kellogg School of Management.
Bruno Francois Jules Angelici active positions
| Companies | Position | Start |
|---|---|---|
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Chairman | - |
Former positions of Bruno Francois Jules Angelici
| Companies | Position | End |
|---|---|---|
| VECTURA GROUP | Chairman | 2021-10-18 |
| SMITHS GROUP PLC | Director/Board Member | 2020-11-15 |
| WOLTERS KLUWER N.V. | Director/Board Member | 2019-04-17 |
| NOVO NORDISK A/S | Director/Board Member | 2017-03-22 |
| ASTRAZENECA PLC | Sales & Marketing | 2009-12-30 |
Training of Bruno Francois Jules Angelici
| Ecole Supérieure de Commerce de Reims | Undergraduate Degree |
| University of Reims Champagne-Ardenne | Graduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| WOLTERS KLUWER N.V. | Technology Services |
| NOVO NORDISK A/S | Health Technology |
| SMITHS GROUP PLC | Producer Manufacturing |
| Private companies | 5 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
Astra Zeneca Holding France SAS
 Astra Zeneca Holding France SAS Pharmaceuticals: MajorHealth Technology Astra Zeneca Holding France SAS operates as a holding firm with interest in pharmaceuticals. The company was founded in 1994 and is headquartered in Rueil-Malmaison, France. | Health Technology |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Health Services |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
- Stock Market
- Insiders
- Bruno Francois Jules Angelici
